⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28485731 | 0.93 | — | — | |
| SCHEMBL28396996 | 0.93 | — | — | |
| SCHEMBL2304704 | 0.93 | — | — | |
| SCHEMBL29615688 | 0.93 | — | — | |
| SCHEMBL28412085 | 0.93 | — | — | |
| Ammonia Solution, Strong SCHEMBL4116843 | 0.93 | — | — | |
| Methane SCHEMBL23726788 | 0.87 | — | — | |
| Nitric Acid SCHEMBL398144 | 0.74 | — | — | |
| SCHEMBL1070026 | 0.72 | — | — | |
| SCHEMBL459148 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2212 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3758679-B1 | NITRIC OXIDE RELEASING SUPPOSITORIES AND METHODS OF USE THEREOF | LIGAND PHARM INC (US) | 2026-05-06 | — | — | EP | claimed |
| EP-4676492-A2 | HIGH PURITY NITRIC OXIDE RELEASING COMPOUNDS AND METHODS OF PREPARING SAME | KNOW Bio, LLC (US) | 2026-01-14 | — | — | EP | claimed |
| EP-4648803-A1 | CONTAINERS AND METHODS FOR NITRIC OXIDE STERILIZATION | Sterile State, LLC (US) | 2025-11-19 | — | — | EP | claimed |
| WO-2025230641-A1 | NITRIC OXIDE-RELEASING LIPOSOMES AS THERAPY FOR RESPIRATORY INFECTIONS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2025-11-06 | — | — | WO | claimed |
| US-20250339449-A1 | INHALATION FORMULATIONS CONTAINING NITRIC OXIDE RELEASING COMPOUNDS AND METHODS OF USING SAME | KNOW BIO, LLC (US) | 2025-11-06 | — | — | US | claimed |
| EP-3629928-B1 | METHOD AND DEVICE FOR DETECTION OF BIOAVAILABLE DRUG CONCENTRATION IN A FLUID SAMPLE | THE UNIV OF TENNESSEE RESEARCH FOUNDATION (US) | 2025-11-05 | — | — | EP | claimed |
| US-20250288607-A1 | METHODS FOR TREATING SEXUAL DYSFUNCTION ASSOCIATED WITH POLYCYSTIC OVARY SYNDROME (PCOS) OR WITH HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD) | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-09-18 | — | — | US | claimed |
| US-20250281512-A1 | BUFFERING AGENT-CONTAINING COMPOSITIONS AND METHODS OF USING SAME | KNOW BIO, LLC (US) | 2025-09-11 | — | — | US | claimed |
| US-12403087-B2 | Topical antiviral compositions, delivery systems, and methods of using the same | LIGAND PHARMACEUTICALS INCORPORATED (US) | 2025-09-02 | — | — | US | claimed |
| US-20250249122-A1 | EXTENDED NITRIC OXIDE-RELEASING POLYMERS VIA FUNCTIONALIZED MESOPOROUS SILICA NANOPARTICLES | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2025-08-07 | — | — | US | claimed |
| WO-2001085227-A2 | NITRIC OXIDE-RELEASING METALLIC MEDICAL DEVICES | MEDTRONIC AVE (US) | 2001-11-15 | — | — | WO | claimed |
| US-20010025052-A1 | Novel nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same | HRABIE JOSEPH A (US) | 2001-09-27 | — | — | US | claimed |
| US-6270779-B1 | HAVING SILANIZED SURFACES COUPLED TO NUCLEOPHILE RESIDUES THAT RELEASE SUSTAINED, THERAPEUTIC AMOUNTS OF NITRIC OXIDE TO SPECIFIC SITES WITHIN A MAMMALIAN BODY | UNITED STATES OF AMERICA | 2001-08-07 | — | — | US | claimed |
| US-6232336-B1 | HYPOTENSIVE AGENTS; NEUROTRANSMISSION; CYTOTOXICITY | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | 2001-05-15 | — | — | US | claimed |
| WO-2001026702-A2 | NITRIC OXIDE-MODIFIED LINEAR POLY(ETHYLENIMINE) FIBERS AND USES THEREFOR | THE UNIVERSITY OF AKRON (US) | 2001-04-19 | — | — | WO | claimed |
| EP-1000023-A2 | NOVEL NITRIC OXIDE-RELEASING AMIDINE- AND ENAMINE-DERIVED DIAZENIUMDIOLATES, COMPOSITIONS AND USES THEREOF AND METHOD OF MAKING SAME | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, represented by THE DEPARTMENT OF HEALTH & HUMAN SERVICES (US) | 2000-05-17 | — | — | EP | claimed |
| EP-0929538-A1 | O?2 -ARYLATED OR O?2 -GLYCOSYLATED 1-SUBSTITUTED DIAZEN-1-IUM-1,2-DIOLATES AND O?2 -SUBSTITUTED 1- (2-CARBOXYLATO)PYRROLIDIN-1-YL]DIAZEN-1-IUM-1,2-DIOLATES | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1999-07-21 | — | — | EP | claimed |
| WO-1999001427-A2 | NOVEL NITRIC OXIDE-RELEASING AMIDINE- AND ENAMINE-DERIVED DIAZENIUMDIOLATES, COMPOSITIONS AND USES THEREOF AND METHOD OF MAKING SAME | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH (US) | 1999-01-14 | — | — | WO | claimed |
| WO-1998013358-A1 | O2-ARYLATED OR O2-GLYCOSYLATED 1-SUBSTITUTED DIAZEN-1-IUM-1,2-DIOLATES AND O2-SUBSTITUTED 1-[(2-CARBOXYLATO)PYRROLIDIN-1-YL]DIAZEN-1-IUM-1,2-DIOLATES | THE UNITED STATES OF AMERICA REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1998-04-02 | — | — | WO | claimed |
| US-5714511-A | Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1998-02-03 | — | — | US | claimed |